Cancer News and Research

Latest Cancer News and Research

NIH awards MacroGenics $9.8 million grant for three projects

MacroGenics, Inc, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that the National Institutes of Health (NIH) has awarded the company three new grants representing total funding of $9.8 million.

15 Jul 2010

IBM dedicates $100 million for global initiative to improve healthcare quality and costs

IBM today announced plans to enlist some of the company's leading scientists and technologists to help medical practitioners and insurance companies provide high-quality, evidence-based care to patients. As part of this initiative, IBM is collaborating with clinicians in medical institutions and hiring medical doctors to work alongside its researchers to develop new technologies, scientific advancements and business processes for healthcare and insurance providers.

15 Jul 2010

NVHR welcomes national HIV/AIDS strategy that recognizes better care for HIV/AIDS, viral hepatitis patients

With millions of Americans living with HIV/AIDS, chronic viral hepatitis, or a combination of both, the National Viral Hepatitis Roundtable welcomes the Administration's recognition of the need for better care coordination and integration of services for these individuals and supports recommendations contained within the new National HIV/AIDS strategy released yesterday in Washington.

15 Jul 2010

Cigarette smoking affects entire networks of gene interaction: Research

The effects of smoking cigarettes on gene activity have been investigated in the largest study of its kind. Researchers writing in the open access journal BMC Medical Genomics studied white blood cells taken from 1,240 people to identify 323 unique genes whose expression levels were significantly correlated with smoking behavior.

15 Jul 2010

Activities of TAT fully consolidated into Geron

Geron Corporation today announced that the activities of TA Therapeutics, its joint venture with Hong Kong University of Science and Technology, are being fully consolidated into Geron.

15 Jul 2010

Eurofins MWG Operon, Genomatix Software offer joint services to develop complete human exome array

Eurofins MWG Operon, an expert in next generation sequencing and Certified Service Provider for Roche NimbleGen sequence capture, together with Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce that they have developed a complete human exome array, based on Roche NimbleGen sequence capture technology.

15 Jul 2010

Plexxikon announces promising preclinical data of PLX3397

Plexxikon Inc. today announced promising preclinical data from in vivo Alzheimer's Disease studies demonstrating a dramatic reduction in activated microglia in the brains of very old (22 months) 3xTG-AD mice, a triple transgenic model for Alzheimer's Disease. This reduction of activated microglia led to significantly improved learning in the treated group.

15 Jul 2010

Positive microplasmin Phase II trial results published in journal Retina

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that positive microplasmin Phase II trial results, evaluating the product for the nonsurgical treatment of vitreomacular adhesion, have been published in the July/August issue of the journal Retina.

15 Jul 2010

NGOC to share expertise with United Network of US Oncology

Northwest Georgia Oncology Centers, a medical practice dedicated to delivering high quality, cost-effective oncology and hematology services to patients in Northwest Georgia, and US Oncology, Inc., the nation's leading integrated oncology company, announced today that NGOC has joined the United Network of US Oncology. The practice, which remains independently owned by its physicians, now has expanded resources from a nationwide network of physicians and clinicians who collaborate to enhance the science and delivery of cancer care.

15 Jul 2010

Medical standard of care triggers biological responses in brain that can fuel tumor cell survival: Researchers

The medical standard of care - comprised of surgery, radiation and chemotherapy - for the most common form of brain cancer triggers a number of biological responses that may actually feed the energy metabolism that supports the disease, according to Boston College researchers writing in the journal Lancet Oncology.

15 Jul 2010

Komen Advocacy Alliance applauds new federal rules for no-cost access to mammography

Susan G. Komen for the Cure® and the Susan G. Komen for the Cure® Advocacy Alliance today applauded new federal rules that will expand access to potentially life-saving care for millions of Americans.

15 Jul 2010

UC San Diego and CTRI receive $37.2M NCRR Clinical and Translational Science Award

The University of California, San Diego Health Sciences and its expanding Clinical and Translational Research Institute (CTRI) have received a five-year, $37.2 million Clinical and Translational Science Award from the National Center for Research Resources (NCRR), part of the National Institutes of Health.

15 Jul 2010

Implantable artificial salivary gland to be developed for Xerostomia patients

The goal of this research was to create an ECM modified hyaluronic acid (HA) based hydrogel culture system that allows for the growth and differentiation of salivary acinar cells into functional acini-like structures capable of secreting large amounts of protein and fluid unidirectionally. Xerostomia, a condition resulting from irradiation of the head and neck, affects more than 40,000 cancer patients each year in the United States. According to this research, these patients will greatly benefit from the development of a functional implantable artificial salivary gland.

15 Jul 2010

Enzyme mTOR regulates autophagy: Study

Cells that consume parts of themselves can stop this process autonomously as well. This was discovered by NWO researcher Judith Klumperman's group, in collaboration with colleagues from the National Institute of Health in Washington. The self-cannibalism is part of the normal digestive process of the cell, but also a survival mechanism in times of famine. This is what makes it difficult for doctors to 'starve out' cancer cells, for instance. The research results were published on 6 June in Nature.

15 Jul 2010

NanoString Technologies increases throughput of nCounter Analysis System

NanoString Technologies, Inc., a privately held life sciences company marketing a novel digital molecular barcoding technology for detecting and counting large sets of targets in biological samples, today announced that it has increased the throughput of its nCounter Analysis System by expanding its multiplexing capacity to 800 gene transcripts per reaction.

From NanoString Technologies 15 Jul 2010

American Heart Association comments on FDA advisory committee's rosiglitazone recommendations

After two days of hearings, an advisory committee to the U.S. Food and Drug Administration (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone (brand name, Avandia), to stay on the market, but with most committee members suggesting that the label be revised to include increased warnings. Rosiglitazone is one in a class of drugs called thiazolidinediones (TZDs), used to treat type 2 diabetes.

15 Jul 2010

Aduro BioTech announces issuance of two important patents

Aduro BioTech, a clinical-stage immunotherapy company, announced today the issuance of two important patents, the formation of a distinguished scientific advisory board, the addition of key members to its Board of Directors, and the reporting of preliminary top line long-term survival data from a Phase 1 clinical trial with 2 year follow-up.

15 Jul 2010

Cervical cancer vaccine could reduce number of cases from 3,000 to less than 700 every year

The cervical cancer vaccine could prevent even more cases of the disease in England than previously thought, UK scientists have found.

15 Jul 2010

Long-term exposure of arsenic may increase risk for lung cancer

To determine how arsenic increases the risk of lung cancer and to identify potential treatments, a Michigan State University researcher will use $1.7 million in federal funding during the next five years to examine why certain genes disrupt cells, leading to the disease.

15 Jul 2010

Kidney Cancer Canada applauds Ontario for granting coverage for RCC therapy TORISEL

Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.

15 Jul 2010

Cancer News and Research

Latest Cancer News and Research

NIH awards MacroGenics $9.8 million grant for three projects

IBM dedicates $100 million for global initiative to improve healthcare quality and costs

NVHR welcomes national HIV/AIDS strategy that recognizes better care for HIV/AIDS, viral hepatitis patients

Cigarette smoking affects entire networks of gene interaction: Research

Activities of TAT fully consolidated into Geron

Eurofins MWG Operon, Genomatix Software offer joint services to develop complete human exome array

Plexxikon announces promising preclinical data of PLX3397

Positive microplasmin Phase II trial results published in journal Retina

NGOC to share expertise with United Network of US Oncology

Medical standard of care triggers biological responses in brain that can fuel tumor cell survival: Researchers

Komen Advocacy Alliance applauds new federal rules for no-cost access to mammography

UC San Diego and CTRI receive $37.2M NCRR Clinical and Translational Science Award

Implantable artificial salivary gland to be developed for Xerostomia patients

Enzyme mTOR regulates autophagy: Study

NanoString Technologies increases throughput of nCounter Analysis System

American Heart Association comments on FDA advisory committee's rosiglitazone recommendations

Aduro BioTech announces issuance of two important patents

Cervical cancer vaccine could reduce number of cases from 3,000 to less than 700 every year

Long-term exposure of arsenic may increase risk for lung cancer

Kidney Cancer Canada applauds Ontario for granting coverage for RCC therapy TORISEL

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in